H. Burks

发表

A novel patient-derived xenograft model for claudin-low triple-negative breast cancer

E. Martin, L. Rhodes, S. Elliott, 2018, Breast Cancer Research and Treatment.

Panobinostat suppresses the mesenchymal phenotype in a novel claudin-low triple negative patient-derived breast cancer model

E. Martin, S. Elliott, B. Collins-Burow, 2018, Oncoscience.

Argonaute 2 Expression Correlates with a Luminal B Breast Cancer Subtype and Induces Estrogen Receptor Alpha Isoform Variation

K. Nephew, B. Rowan, E. Martin, 2016, Non-coding RNA.

Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor

H. Wathieu, S. Elliott, B. Collins-Burow, 2019, bioRxiv.

Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor

H. Wathieu, S. Elliott, B. Collins-Burow, 2019, bioRxiv.

Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulators

D. Chrisey, B. Rowan, L. Rhodes, 2014, Breast Cancer Research and Treatment.

ZEB2 regulates endocrine therapy sensitivity and metastasis in luminal a breast cancer cells through a non-canonical mechanism

K. Nephew, D. Rusch, D. Chrisey, 2021, Breast Cancer Research and Treatment.

A novel screening approach comparing kinase activity of small molecule inhibitors with similar molecular structures and distinct biologic effects in triple-negative breast cancer to identify targetable signaling pathways

K. Nephew, D. Rusch, D. Drewry, 2020, Anti-cancer drugs.

Translational implications of Th17-skewed inflammation due to genetic deficiency of a cadherin stress sensor

E. Sprecher, C. Missero, L. Tsoi, 2020, bioRxiv.

Liver Kinase B1 Regulates Remodeling of the Tumor Microenvironment in Triple-Negative Breast Cancer

E. Martin, S. Elliott, B. Collins-Burow, 2022, Frontiers in Molecular Biosciences.

Keratinocyte cadherin desmoglein 1 controls melanocyte behavior through paracrine signaling

K. Green, Jodi L. Johnson, P. Gerami, 2020, Pigment cell & melanoma research.

Application of a small molecule inhibitor screen approach to identify CXCR4 downstream signaling pathways that promote a mesenchymal and fulvestrant-resistant phenotype in breast cancer cells

D. Drewry, W. Zuercher, E. Martin, 2021, Oncology letters.

Desmoglein 1 Regulates Invadopodia by Suppressing EGFR/Erk Signaling in an Erbin-Dependent Manner

L. Godsel, K. Green, H. Burks, 2019, Molecular Cancer Research.

Transcriptional profiling of rare acantholytic disorders suggests common mechanisms of pathogenesis

L. Tsoi, J. Gudjonsson, X. Xing, 2022, bioRxiv.

miR-155 induced transcriptome changes in the MCF-7 breast cancer cell line leads to enhanced mitogen activated protein kinase signaling

E. Flemington, E. Martin, S. Elliott, 2014, Genes & cancer.

Novel application of the published kinase inhibitor set to identify therapeutic targets and pathways in triple negative breast cancer subtypes

D. Drewry, W. Zuercher, C. Wells, 2017, PloS one.

Leptin produced by obesity-altered adipose stem cells promotes metastasis but not tumorigenesis of triple-negative breast cancer in orthotopic xenograft and patient-derived xenograft models

L. Del Valle, B. Collins-Burow, M. Burow, 2019, Breast Cancer Research.

Laser Direct‐Write Onto Live Tissues: A Novel Model for Studying Cancer Cell Migration

Walter L Murfee, D. Chrisey, B. Collins-Burow, 2016, Journal of cellular physiology.

Endocrine disruptors and the tumor microenvironment: A new paradigm in breast cancer biology

J. McLachlan, E. Martin, M. Burow, 2017, Molecular and Cellular Endocrinology.

Crosstalk in skin: Loss of desmoglein 1 in keratinocytes inhibits BRAFV600E-induced cellular senescence in human melanocytes

Xin Tong, K. Green, Z. Ren, 2023, bioRxiv.

Dual Src Kinase/Pretubulin Inhibitor KX-01, Sensitizes ERα-negative Breast Cancers to Tamoxifen through ERα Reexpression

B. Rowan, B. Collins-Burow, M. Burow, 2017, Molecular Cancer Research.

In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within rare tumor types

H. Wathieu, E. Flemington, E. Martin, 2021, Clinical and Translational Oncology.

Keratinocyte desmosomal cadherin Desmoglein 1 as a mediator and target of paracrine signaling in the melanoma niche

K. Green, J. Pokorny, Jodi L. Johnson, 2022, bioRxiv.

ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast Cancer

K. Nephew, L. Del Valle, Jane E. Cavanaugh, 2020, Frontiers in Oncology.

NEK5 activity regulates the mesenchymal and migratory phenotype in breast cancer cells

K. Nephew, D. Drewry, W. Zuercher, 2021, Breast Cancer Research and Treatment.

A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma

R. Carvajal, S. Piperno-Neumann, M. Carlino, 2023, British Journal of Cancer.

Glyceollin I Reverses Epithelial to Mesenchymal Transition in Letrozole Resistant Breast Cancer through ZEB1

Matthew E. Burow, B. Collins-Burow, M. Burow, 2015, International journal of environmental research and public health.

Regulation of triple-negative breast cancer cell metastasis by the tumor-suppressor liver kinase B1

K. Nephew, D. Rusch, E. Martin, 2015, Oncogenesis.

Constitutive activation of MEK5 promotes a mesenchymal and migratory cell phenotype in triple negative breast cancer

K. Nephew, D. Rusch, Jane E. Cavanaugh, 2021, Oncoscience.

Dual inhibition of MEK1/2 and MEK5 suppresses the EMT/migration axis in triple‐negative breast cancer through FRA‐1 regulation

K. Nephew, D. Rusch, D. Chrisey, 2021, Journal of cellular biochemistry.

225 Desmoglein 1 deficiency in knockout mice impairs epidermal barrier formation and results in a psoriasis-like gene signature in E18.5 embryos

C. Missero, L. Tsoi, J. Gudjonsson, 2020, Journal of Investigative Dermatology.

Aging is associated with impaired angiogenesis, but normal microvascular network structure, in the rat mesentery.

L. Myers, M. Baddoo, R. Sweat, 2017, American journal of physiology. Heart and circulatory physiology.

ZEB2 Regulates Endocrine Therapy Sensitivity and Metastasis in Luminal A Breast Cancer Through a Non-Canonical Mechanism

H. Burks, 2021 .

Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model

B. Rowan, E. Martin, L. Rhodes, 2019, BMC Cancer.

Melanoma cells repress Desmoglein 1 in keratinocytes to promote tumor cell migration.

Jodi L. Johnson, J. Seykora, P. Gerami, 2023, The Journal of cell biology.

Correction: Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor

H. Wathieu, S. Elliott, B. Collins-Burow, 2021, PLoS ONE.